Zurueck zur Suche

Reporte zur Charge KH3N5

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 3 MT 1

VAERS 2527893

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge KH3N5

mild
Staat
CA
Alter
16,0
Geschlecht
M
Eingang
09.12.2022
Impfdatum
02.12.2022
Beginn
01.12.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Chills Dizziness Erythema Peripheral swelling

Symptomtext

TIME OF VACCINE EXPERIENCED WEAKNESS AND DIZZINESS. OBSERVED 20-30 MIN PT RETURNED TODAY WITH RT ARM REDENESS SWELLING , INTERMITTENT SHIVERING,

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
CLARITIN / CLINDAMYCIN
Allergien
NONE
Vorherige Impfungen
-

VAERS 2481310

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge KH3N5

mild
Staat
CA
Alter
11,0
Geschlecht
M
Eingang
18.10.2022
Impfdatum
10.10.2022
Beginn
11.10.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site mass Injection site swelling

Symptomtext

Redness at the injection site; Swelling at the injection site; Bumps at the injection site; This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a 11-year-old male patient who received Flu Seasonal QIV (FluLaval Quadrivalent 2022-2023 season) (batch number KH3N5, expiry date 16th June 2023) for prophylaxis. Co-suspect products included flu seasonal qiv pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 10th October 2022, the patient received FluLaval Quadrivalent 2022-2023 season and Flulaval Tetra Pre-Filled Syringe Device. On 11th October 2022, 1 days after receiving FluLaval Quadrivalent 2022-2023 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced injection site erythema, injection site swelling and injection site mass. On an unknown date, the outcome of the injection site erythema, injection site swelling and injection site mass were unknown. It was unknown if the reporter considered the injection site erythema, injection site swelling and injection site mass to be related to FluLaval Quadrivalent 2022-2023 season and Flulaval Tetra Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-Oct-2022 Reporter's comment: The healthcare professionals reported that the patient received the Flulalval Quadrivalent on left deltoid. The patient experience local redness, swelling, and bumps at the injection site. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up via postal.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2475767

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge kh3n5

mild
Staat
CA
Alter
11,0
Geschlecht
M
Eingang
11.10.2022
Impfdatum
10.10.2022
Beginn
11.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site vesicles Injection site warmth Local reaction Pain

Symptomtext

Patient was sore. Mom applied heating pad at night. Patient woke up with a local reaction. Site was tender, red, warm and had blister-like bumps just below site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none known
Vorgeschichte
none
Andere Medikamente
daily multivitamins, probiotics
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2422798

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge KH3N5

mild
Staat
MT
Alter
7,0
Geschlecht
M
Eingang
29.08.2022
Impfdatum
26.08.2022
Beginn
26.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash papular

Symptomtext

DIFFUSE PAPULAR RASH APPROXIMATELY 30-45 MIN AFTER INJECTION

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash papular
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
ADHD
Andere Medikamente
CONCERTA 18MG DAILY
Allergien
ALOE VERA - RASH
Vorherige Impfungen
-